INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Valion Bio, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERVBIO
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / VBIO COVERAGE

What’s moving Valion Bio, Inc. now

Current reporting with the operating signal separated from the noise.

01
Valion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial Results

Valion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial Results

The story matters when it changes Valion Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest VBIO filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-14 · Period 2026-07-14SEC ↗8-KMaterial company eventFiled 2026-06-18 · Period 2026-06-17SEC ↗8-KMaterial company eventFiled 2026-06-03 · Period 2026-05-28SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-17 · Period 2026-08-14SEC ↗SCHEDULE 13DOfficial SEC filingFiled 2026-08-03SEC ↗
EARNINGS / QUARTERLY TRACKER

Valion Bio, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.